The role of corticosteroids binding to blood plasma proteins in irradiated animals in the implementation of radioprotective effects

«Radiation and Risk», 2023, vol. 32, No. 4, pp.54-66

DOI: 10.21870/0131-3878-2023-32-4-54-66

Authors

Omelchuk N.N. – Head of Dep., Assoc. Prof., D. Sc., Biol. PFUR. Contacts: 6 Miklukho-Maklay str., Moscow, Russia, 117198. Tel.: 8-916-908-11-10; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Patrice Lumumba Peoples' Friendship University of Russia, Moscow

Abstract

The article presents a comparative analysis of radioprotectors RS-10 and RS-11 ability to enhance radioresistance in animals exposed to radiation that is based on results of research on protein-steroid interaction in acute radiation sickness. The importance of the research is caused by the need to conduct a comprehensive analysis of the mechanisms of radioprotective action of synthetic radioprotectors, including the revealing of the role of corticosteroid binding to blood plasma proteins in irradiated animals. The aim of the research was to investigate the impact of RS-10 and RS-11 radioprotectors on the binding of corticosteroids to blood plasma proteins in irradiated animals. 90 male Chinchilla rabbits weighing 2.5-3.0 kg were included in the experimental research. At the initial stage of the research the response of the adrenal cortex and the processes of their binding to blood plasma proteins after administration of RS-10 and RS-11 to intact animals was studied; at the next stage the same rates were used for the follow-up of the animals exposed to radiation after prophylactic administration of the radioprotectors. The rabbits were totally irradiated with gamma rays at a dose of 8 Gy that caused acute radiation sickness of the IV degree. The RS-10 (chitosan bitartrate) at the dose of 10.0 mg/kg and the RS-11 (similar to RS-10, but with a lower average molecular mass) at the dose of 2-7 mg/kg were intravenously injected to rabbits 15 minutes before the irradiation. Control animals were injected with an equal volume of the saline. The total content of 11-oxycorticosteroids (11-OCS) in the blood plasma was quantitated with the use of the fluorometric method in the author's modification. The amount of free corticosteroids was quantified as the difference between their content in the whole plasma and in its protein fraction after the gel-filtration chromatography with Sephadex G-25. The binding capacity of corticosteroid-binding globulin (CBG) was determined by gel filtration in the author's modification. The results of the study demonstrated the rise of the concentration of the blood plasma corticosteroids in the first hours after the RS-10 and RS-11 injection to intact animals, the amount of the free hormone increased as well. The effect of RS-10 on the rise of the free hormone levels was more pronounced as compared to the RS-11 effect. The impact of both radioprotectors on the elevation of the amount of 11-OCS binding to blood plasma proteins was similar. The introduction of RS-10 and RS-11 to the animals did not have effect on the binding capacity of the blood plasma proteins. The mechanism of radioprotective action of RS-10 and RS-11 in irradiated animals is the establishment of the optimal response of the adrenal cortex in the first hours after irradiation. The difference of the early adrenocortical response in animals irradiated and protected due to the injection of RS-10 and RS-11 from the optimal response varying towards strengthening or weakening, is the indicator of the radiation sickness severity. Prophylactic administration of RS-10 and RS-11 to irradiated animals at the height of the disease inhibited the reduction of the binding capacity of the CBG, resulting in the rise of the free hormone level at the higher total level of hormones in the blood is inhibited as well. In the mechanism for reducing post-radiation hypercorticism, with the use of the radioprotectors of RS-10 and RS-11, the main importance is the lower degree of the CBG binding capacity impairment rather than the change in the overall level of blood hormones. The higher prophylactic effect of RS-11 compared to RS-10 is confirmed by the significantly high rate of the binding ability of the CBG at the height of radiation sickness and the lower mortality among the animals involved in the experimental research.

Key words
acute radiation sickness, radioprotectors, RS-10, RS-11, protein-steroid interaction, corticosteroids, free hormone.

References

1. Anokhin P.K. Essays on the physiology of functional systems. Moscow, Book on Demand, 2021. 450 p. (In Russian).

2. Grebenyuk A.N., Strelova O.Yu., Legeza V.I., Stepanova E.N. Fundamentals of radiobiology and radiation medicine: textbook. St. Petersburg, LLC FOLIANT Publishing House, 2012. 232 p. (In Russian).

3. Dokshina G.A. Endocrine and metabolic aspects of radiation sickness. Tomsk, Tomsk University Publishing House, 1984. 223 p. (In Russian).

4. Kuzin A.M. Structural-metabolic theory in radiobiology. Moscow, Nauka, 1986. 282 p. (In Russian).

5. Rozhdestvensky L.M. Past and future of radiobiology of anti-radiation agents at the Institute of Biophysics of the USSR Ministry of Health – A.I. Burnazyan FMBC FMBA of Russia. Collection of articles dedicated to the 70th anniversary of the A.I. Burnazyan FMBC FMBA of Russia (1946-2016). Eds.: L.A. Ilin, V.V. Uyba, A.S. Samoylov. Moscow, 2016, pp. 80-89. (In Russian).

6. Vasin M.V. Classification of anti-radiation agents as a reflection of the current state and prospects for the development of radiation pharmacology. Radiatsionnaya biologiya. Radioekologiya – Radiation Biology. Radioecology, 2013, vol. 53, no. 5, pp. 459-467. (In Russian).

7. Legeza V.I., Vladimirov V.G. New classification of prophylactic anti-radiation agents. Radiatsionnaya biologiya. Radioekologiya – Radiation Biology. Radioecology, 1998, vol. 8, no. 3, pp. 416-425. (In Russian).

8. Rozhdestvensky L.M. Classification of anti-radiation drugs in terms of their pharmacological signal and conjugation with the stage of development of radiation injury. Radiatsionnaya biologiya. Radioekologiya – Radiation Biology. Radioecology, 2017, vol. 57, no. 2, pp. 118-135. (In Russian).

9. Rozhdestvensky L.M. Problems of the development of domestic anti-radiation agents in the crisis period: the search for relevant development directions. Radiatsionnaya biologiya. Radioekologiya – Radiation Biology. Radioecology, 2020, vol. 60, no. 3, pp. 279-290. (In Russian).

10. Khabriev R.U., Mingazova E.N., Sidorov V.V., Gureev S.A., Yusupova M.M. Biocompatible drugs-protectors against the effects of radiation: a modern view of the problem. Remedium – Remedium, 2021, vol. 25, no. 4, pp. 3-8. (In Russian).

11. Kashiwakura I. Overview of radiation-protective agent research and prospects for the future. Jpn. J. Health Phys., 2017, vol. 52, no.4, pp. 285-295.

12. Koukourakis M.I. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br. J. Radiol., 2012, vol. 85, no. 1012, pp. 313-330.

13. Volkova L.V., Pashov A.I., Omelchuk N.N. Cervical carcinoma: oncobiology and biomarkers. Int. J. Mol. Sci., 2021, vol. 22, no. 22, pp. 12571. DOI: 10.3390/ijms222212571.

14. Kilic S., Cracchiolo B., Gabel M., Haffty B., Mahmoud O. The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy. Ann. Transl. Med., 2015, vol. 3, no. 18, pp. 261. DOI: 10.3978/j.issn.2305-5839.2015.10.18.

15. Qin Ch., Chen X., Bai Q., Davis M.R., Fang Y. Factor associated with radiosensitivity of cervical cancer. Anticancer Res., 2014, vol. 34, no. 9, pp. 4649-4656.

16. Sood S., Patel F.D., Srinivasan R., Dhaliwal L.K. Chemoradiation therapy induces in vivo changes in gene promoter methylation & gene transcript expression in patients with invasive cervical cancer. Indian J. Med. Res., 2018, vol. 147, no. 2, pp. 151-157.

17. Rozhdestvensky L.M., Fedotova M.I., Romanov A.I., Belousova O.I. About ways of implementation and mechanisms of anti-radiation action of RS-10, mercamin and mexamine. Radiatsionnaya biologiya. Radioekologiya – Radiation Biology. Radioecology, 2017, vol. 57, no. 5, pp. 540-544. (In Russian).

18. Horizontov P.D., Razorenova V.A., Sbitneva M.F., Andrianova I.E. Radioprotective and therapeutic efficacy of the drug RS-10 in experiments on dogs. Radiatsionnaya biologiya. Radioekologiya – Radiation Biology. Radioecology, 2017, vol. 57, no. 5, pp. 529-539. (In Russian).

19. Davydova S.A., Trushina M.N., Vodyakova L.M. Results of commission tests of the drug RS-10 as a means of early treatment of acute radiation sickness. Selected materials of the Bulletin of Radiation Medicine. Vol. 1. Eds.: L.A. Ilyin, A.S. Samoilov. Moscow, A.I. Burnazyan FMBC FMBA of Russia, 2016, pp. 571-582. (In Russian).

20. Chernov G.A., Evdakov V.P., Kabanov V.A. Antiradiation effect of ionogenic polymers. Selected materials of the Bulletin of Radiation Medicine. Vol. 2. Eds. Eds.: L.A. Ilyin, A.S. Samoilov. Moscow, A.I. Burnazyan FMBC FMBA of Russia, 2016, pp. 607-619. (In Russian).

21. Omelchuk N.N. Actual issues of prevention of acute radiation sickness. Natsionalnoye zdorovye – National Health, 2018, no. 1, pp. 70-75. (In Russian).

22. Guillemin R., Clayton G., Lipscomb H., Smith J. Fluorometric measurement of rat plasma and adrenal corticosterone concentration; a note on technical details. J. Lab. Clin. Med., 1959, vol. 53, no. 5, pp. 830-832.

23. De Moor P., Hoirwegh K., Heromans G., Declerck-Raskin M.M. Protein binding of corticosteroid studied by gel filtration. J. Clin. Invest., 1962, vol. 41, no. 4, pp. 816-827.

24. Omelchuk N.N. Methods for assessing protein-steroid interaction in the pathogenesis of acute radiation sickness. International Journal of Medicine and Psychology, 2023, vol. 6, no. 1, pp. 178-183. (In Russian).

Full-text article (in Russian)